ArticleAnnals of the rheumatic diseases2023

Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study.

Viking Huss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.